The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 22, 2024
Filed:
Feb. 24, 2021
Applicant:
Serpentide Inc., Hangzhou, CN;
Inventor:
Yang Wei, Yorktown Heights, NY (US);
Assignee:
SERPENTIDE INC., Hangzhou, CN;
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/26 (2006.01); A61K 39/395 (2006.01); A61K 45/06 (2006.01); A61P 3/10 (2006.01); C07K 14/605 (2006.01); C07K 16/28 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/605 (2013.01); A61K 38/26 (2013.01); A61K 39/3955 (2013.01); A61K 45/06 (2013.01); A61P 3/10 (2018.01); C07K 16/28 (2013.01); C07K 16/2869 (2013.01); A61K 2039/505 (2013.01); C07K 2317/31 (2013.01); C07K 2317/55 (2013.01); C07K 2319/30 (2013.01); C07K 2319/35 (2013.01); C07K 2319/50 (2013.01);
Abstract
Modified glucagon-like peptide (GLP1) fusion proteins with modified GLP1 polypeptides and related methods of use are described. Aspects of the disclosure further relate to fusion proteins that are GLP1 receptor agonists with a modified GLP1 fused to a stabilizing domain such as an extra cellular domain or antibody. Fusion proteins with modified GLP1 that are useful for treating or ameliorating a symptom or indication of a blood sugar disorder such as obesity and diabetes are also provided.